🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 648.57 -1.7% NASDAQ 100: 582.06 -1.9% Dow Jones: 455.89 -1.1%

Phreesia, Inc.

PHR Healthcare
$11.86 +$0.09 (0.76%)
Market Cap: $715 M
Gurus Holding
6
Popularity Rank
#1301
% of Shares Held
1.85%
Net Activity (Q4 2025)
+$3.48 M

Guru Ownership Trend

Guru Analysis for Phreesia, Inc. (PHR)

Phreesia, Inc. (PHR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.24 M.

Top institutional holders include Cliff Asness and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $3.48 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 140.9%. Conversely, Ray Dalio reduced exposure by 82.3%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$8.62 M
Total Buy Value
New Buys 2
Additions 2
-$5.14 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
4

FAQs for Phreesia, Inc. (PHR)

Major holders include Cliff Asness ($7.4 M), Paul Tudor Jones ($5.7 M), Steven Cohen ($3.99 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.12 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3.48 M, with 4 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited PHR. The total reported sell value was $5.14 M.

Yes, 2 managers opened new positions in PHR, and 2 increased their existing holdings. The total reported buy value was $8.62 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 140.9% 437,094 $7.4 M Q4 2025
0.01% Add 89.8% 336,663 $5.7 M Q4 2025
0.00% Reduce -50.9% 235,615 $3.99 M Q4 2025
0.02% New Buy 67,763 $1.15 M Q4 2025
0.00% New Buy 26,500 $448,380 Q4 2025
0.00% Reduce -82.3% 12,805 $216,661 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form